Article
Clinical Significance of OX40 and OX40 Ligand in the Peripheral Blood of Patients with…
Journal of Immunology Research · 2021 · Xiaoling Zhou, author Xiaoyuan Wang, author Yanzheng Gu, author Lan Chen, author Yueping Shen, author Jingluan Tian, author Chen Shujun, author Mingyuan Wang, author Xiaoyu Duan, author Hanqing Gao, author Xiaopei Ji, author Qi Fang, author Xueguang Zhang, author Qun Xue, author Shengjun Wang, Academic Editor
Key facts
| Title | Clinical Significance of OX40 and OX40 Ligand in the Peripheral Blood of Patients with Myasthenia Gravis |
|---|---|
| First author | Xiaoling Zhou, author Xiaoyuan Wang, author Yanzheng Gu, author Lan Chen, author Yueping Shen, author Jingluan Tian, author Chen Shujun, author Mingyuan Wang, author Xiaoyu Duan, author Hanqing Gao, author Xiaopei Ji, author Qi Fang, author Xueguang Zhang, author Qun Xue, author Shengjun Wang, Academic Editor |
| Journal | Journal of Immunology Research |
| Published | Sep 14, 2021 |
| DOI | 10.1155/2022/4337399 |
| Product codes mentioned | MVU |
At a glance
- None FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1